Literature DB >> 6754812

In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon.

C Boitard, L M Chatenoud, M Debray-Sachs.   

Abstract

Lymphocytes from insulin-dependent diabetic patients were previously shown to suppress insulin release from mouse islet cells in vitro. Glucagon release was not suppressed. In order to further analyze this phenomenon, lymphocytes from three insulin-dependent diabetic patients with associated autoimmune diseases were treated by using the panning method for cell separation before testing on islet cell suspensions. The OKT3+, OKT3-, and OKT4- cell subsets were obtained. Insulin release was suppressed by the OKT3+ (T lymphocyte-enriched) subset, but not by the OKT3- (T lymphocyte-depleted) subset. These results suggest that T lymphocytes are directly involved in the suppression of insulin release in this model. Furthermore, the OKT4- (T helper-depleted) subset also suppressed insulin release.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754812

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

2.  Oligodendrocyte-specific autoreactive T cells using an alpha/beta T-cell receptor kill their target without self restriction.

Authors:  V Jewtoukoff; R Lebar; M A Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 3.  Mechanisms of autoimmunity in insulin-dependent diabetes mellitus.

Authors:  J F Bach
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

Review 4.  Immunological concepts in insulin-dependent (type I) diabetes mellitus.

Authors:  A Etzioni
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 5.  Cellular basis of T-cell autoreactivity in autoimmune diseases.

Authors:  C Carnaud; J F Bach
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 6.  IDDM: an islet or an immune disease?

Authors:  C Boitard; E Larger; J Timsit; P Sempe; J F Bach
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

7.  Immunologic factors in pathogenesis and treatment of human and animal diabetes.

Authors:  A Naji; W K Silvers; S T Bartlett; J Francfort; C F Barker
Journal:  World J Surg       Date:  1984-04       Impact factor: 3.352

Review 8.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

9.  Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.

Authors:  A V Zavala; L E Fabiano de Bruno; A I Cardoso; A H Mota; M Capucchio; E Poskus; L Fainboim; J C Basabe
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

10.  The immunological basis of inflammatory diseases.

Authors:  J F Bach
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.